Xi Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xi Liu has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Bing Sun
Nanjing Aoyin Biotechnology Co., Ltd., Nanjing, China
15 shared publications - Huakan Zhao
Chongqing University Cancer Hospital, School of Medicine, Chongqing University, Chongqing, China
15 shared publications - Jiangang Zhang
Department of Medical Oncology, Chongqing University Cancer Hospital, Chongqing, China
15 shared publications - Jinwei Cui
Nanjing Aoyin Biotechnology Co., Ltd., Nanjing, China
15 shared publications - Jun Zhang
Nanjing Aoyin Biotechnology Co., Ltd., Nanjing, China
15 shared publications - Lei Wu
Department of Medical Oncology, Chongqing University Cancer Hospital, Chongqing, China
15 shared publications
Latest Publications
- Open Access
- 1 August 2025
- Published by American Association for Cancer Research (AACR)
Table S3 from Single-Cell Analysis of Posttranslational Modifications Identifies Immunosuppressive Macrophage Subtypes in the HBV-Positive Hepatocellular Carcinoma Microenvironment
Statistical information related to Fig.1F and 1G
- 1 August 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S3 from Single-Cell Analysis of Posttranslational Modifications Identifies Immunosuppressive Macrophage Subtypes in the HBV-Positive Hepatocellular Carcinoma Microenvironment
Statistical information related to Fig.1F and 1G
- Open Access
- 1 August 2025
- Published by American Association for Cancer Research (AACR)
Figure S6 from Single-Cell Analysis of Posttranslational Modifications Identifies Immunosuppressive Macrophage Subtypes in the HBV-Positive Hepatocellular Carcinoma Microenvironment
Comparison of the TME of HR and LR using IMC data.
- 1 August 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S6 from Single-Cell Analysis of Posttranslational Modifications Identifies Immunosuppressive Macrophage Subtypes in the HBV-Positive Hepatocellular Carcinoma Microenvironment
Comparison of the TME of HR and LR using IMC data.
- Open Access
- 1 August 2025
- Published by American Association for Cancer Research (AACR)
Figure S8 from Single-Cell Analysis of Posttranslational Modifications Identifies Immunosuppressive Macrophage Subtypes in the HBV-Positive Hepatocellular Carcinoma Microenvironment
The workflow of integrative single-cell PTM omics
- 1 August 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S8 from Single-Cell Analysis of Posttranslational Modifications Identifies Immunosuppressive Macrophage Subtypes in the HBV-Positive Hepatocellular Carcinoma Microenvironment
The workflow of integrative single-cell PTM omics
- Open Access
- 1 August 2025
- Published by American Association for Cancer Research (AACR)
Table S1 from Single-Cell Analysis of Posttranslational Modifications Identifies Immunosuppressive Macrophage Subtypes in the HBV-Positive Hepatocellular Carcinoma Microenvironment
Summary of clinicopathological information and characteristics of the enrolled 53 patients with HCC
- 1 August 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S1 from Single-Cell Analysis of Posttranslational Modifications Identifies Immunosuppressive Macrophage Subtypes in the HBV-Positive Hepatocellular Carcinoma Microenvironment
Summary of clinicopathological information and characteristics of the enrolled 53 patients with HCC
- Open Access
- 1 August 2025
- Published by American Association for Cancer Research (AACR)
Table S2 from Single-Cell Analysis of Posttranslational Modifications Identifies Immunosuppressive Macrophage Subtypes in the HBV-Positive Hepatocellular Carcinoma Microenvironment
Metal antibodies used for IMC.
- 1 August 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S2 from Single-Cell Analysis of Posttranslational Modifications Identifies Immunosuppressive Macrophage Subtypes in the HBV-Positive Hepatocellular Carcinoma Microenvironment
Metal antibodies used for IMC.
- Open Access
- 1 August 2025
- Published by American Association for Cancer Research (AACR)
Figure S4 from Single-Cell Analysis of Posttranslational Modifications Identifies Immunosuppressive Macrophage Subtypes in the HBV-Positive Hepatocellular Carcinoma Microenvironment
The expression levels of phosphorylated HSP27 (p-HSP27, S82), phosphorylated STAT1 (p-STAT1, S727), and phosphorylated TRIM28 (p-TRIM28, S473) in TAMs
- 1 August 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from Single-Cell Analysis of Posttranslational Modifications Identifies Immunosuppressive Macrophage Subtypes in the HBV-Positive Hepatocellular Carcinoma Microenvironment
The expression levels of phosphorylated HSP27 (p-HSP27, S82), phosphorylated STAT1 (p-STAT1, S727), and phosphorylated TRIM28 (p-TRIM28, S473) in TAMs
- Open Access
- 1 August 2025
- Published by American Association for Cancer Research (AACR)
Figure S7 from Single-Cell Analysis of Posttranslational Modifications Identifies Immunosuppressive Macrophage Subtypes in the HBV-Positive Hepatocellular Carcinoma Microenvironment
Comparison of the spatial feature TME of HR and LR using IMC data.
- 1 August 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S7 from Single-Cell Analysis of Posttranslational Modifications Identifies Immunosuppressive Macrophage Subtypes in the HBV-Positive Hepatocellular Carcinoma Microenvironment
Comparison of the spatial feature TME of HR and LR using IMC data.
- Open Access
- 1 August 2025
- Published by American Association for Cancer Research (AACR)
Figure S1 from Single-Cell Analysis of Posttranslational Modifications Identifies Immunosuppressive Macrophage Subtypes in the HBV-Positive Hepatocellular Carcinoma Microenvironment
Proportion of immune cells in CT versus AT.
- 1 August 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from Single-Cell Analysis of Posttranslational Modifications Identifies Immunosuppressive Macrophage Subtypes in the HBV-Positive Hepatocellular Carcinoma Microenvironment
Proportion of immune cells in CT versus AT.
- Open Access
- 1 August 2025
- Published by American Association for Cancer Research (AACR)
Figure S5 from Single-Cell Analysis of Posttranslational Modifications Identifies Immunosuppressive Macrophage Subtypes in the HBV-Positive Hepatocellular Carcinoma Microenvironment
Subtyping M2 macrophages based on profiles of p-HSP27, p-STAT1, and p-TRIM28.
- 1 August 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5 from Single-Cell Analysis of Posttranslational Modifications Identifies Immunosuppressive Macrophage Subtypes in the HBV-Positive Hepatocellular Carcinoma Microenvironment
Subtyping M2 macrophages based on profiles of p-HSP27, p-STAT1, and p-TRIM28.
- Open Access
- 1 August 2025
- Published by American Association for Cancer Research (AACR)
Data from Single-Cell Analysis of Posttranslational Modifications Identifies Immunosuppressive Macrophage Subtypes in the HBV-Positive Hepatocellular Carcinoma Microenvironment
Analysis of posttranslational modifications (PTM) of proteins can provide new insights, beyond those obtained from analysis of protein levels, for understanding the tumor microenvironment (TME). The characteristics of PTMs in immune cells, along with their spatial distribution, have not been comprehensively integrated, which impedes our understanding of the complexity and heterogeneity of the TME in hepatocellular carcinoma (HCC). In this study, we used a strategy that combines antibodies for specific PTMs with mass cytometry and mass spectrometry technologies to identify PTMs at single-cell resolution. We found that the phosphorylation status of M2 macrophages was substantially altered in tumor tissues from patients with hepatitis B virus (HBV)–positive HCC. Utilizing the expression profiles of site-specific phospho–heat shock protein 27, signal transducer and activator of transcription 1, and tripartite motif–containing protein 28, we classified M2 macrophages into four distinct subtypes: M2-P0 (absence of any of the three phospho-proteins), M2-P1 (presence of one of the three phospho-proteins), M2-P2 (presence of two of the three phospho-proteins), and M2-P3 (presence of all three phospho-proteins). The spatial relationships and functional characteristics of these M2 macrophage subpopulations were assessed using single-cell PTM omics. The abundance of the M2-P2 and M2-P3 subtypes was closely associated with an immunosuppressive TME and responsiveness to immunotherapy in HBV+ HCC. Overall, this study introduces a single-cell PTM-omics approach that uncovers subtypes of macrophages associated with immunotherapeutic responses in HBV+ HCC and provides valuable insights into the immunosuppressive TME of HCC.
- 1 August 2025
- Published by American Association for Cancer Research (AACR)
Open AccessData from Single-Cell Analysis of Posttranslational Modifications Identifies Immunosuppressive Macrophage Subtypes in the HBV-Positive Hepatocellular Carcinoma Microenvironment
Analysis of posttranslational modifications (PTM) of proteins can provide new insights, beyond those obtained from analysis of protein levels, for understanding the tumor microenvironment (TME). The characteristics of PTMs in immune cells, along with their spatial distribution, have not been comprehensively integrated, which impedes our understanding of the complexity and heterogeneity of the TME in hepatocellular carcinoma (HCC). In this study, we used a strategy that combines antibodies for specific PTMs with mass cytometry and mass spectrometry technologies to identify PTMs at single-cell resolution. We found that the phosphorylation status of M2 macrophages was substantially altered in tumor tissues from patients with hepatitis B virus (HBV)–positive HCC. Utilizing the expression profiles of site-specific phospho–heat shock protein 27, signal transducer and activator of transcription 1, and tripartite motif–containing protein 28, we classified M2 macrophages into four distinct subtypes: M2-P0 (absence of any of the three phospho-proteins), M2-P1 (presence of one of the three phospho-proteins), M2-P2 (presence of two of the three phospho-proteins), and M2-P3 (presence of all three phospho-proteins). The spatial relationships and functional characteristics of these M2 macrophage subpopulations were assessed using single-cell PTM omics. The abundance of the M2-P2 and M2-P3 subtypes was closely associated with an immunosuppressive TME and responsiveness to immunotherapy in HBV+ HCC. Overall, this study introduces a single-cell PTM-omics approach that uncovers subtypes of macrophages associated with immunotherapeutic responses in HBV+ HCC and provides valuable insights into the immunosuppressive TME of HCC.